questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Composants de génome
Gènes
Composants de gène
Régions non traduites
Régions 3' non traduites
Régions 3' non traduites : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Séquençage de l'ARN
Analyse bioinformatique
Électrophorèse
ARN messager
Mutations génétiques
Séquençage ciblé
Stabilité de l'ARN
Expression génique
Symptômes
5
Anomalies génétiques
Symptômes cliniques
Maladies génétiques
Symptômes
Réponse au traitement
Expression génique
Syndromes génétiques
Mutations
Prévention
5
Dépistage génétique
Prévention des maladies
Mode de vie sain
Tests génétiques
Antécédents familiaux
Risques génétiques
Programmes de prévention
Sensibilisation
Mode de vie
Expression génique
Traitements
5
Thérapie génique
Traitement médicamenteux
Thérapies ciblées
Expression génique
Modification génétique
Recherche médicale
Régulation génique
Traitements
Médicaments
Recherche pharmacologique
Complications
5
Complications médicales
Troubles génétiques
Cancers
Altérations génétiques
Troubles neurologiques
Mutations génétiques
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Facteurs environnementaux
Expression génique
Habitudes de vie
Tabagisme
Mutations
Régions codantes
Tests génétiques
Évaluation des risques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Régions 3' non traduites : Questions médicales les plus fréquentes",
"headline": "Régions 3' non traduites : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Régions 3' non traduites : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-30",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Régions 3' non traduites"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Régions non traduites",
"url": "https://questionsmedicales.fr/mesh/D020506",
"about": {
"@type": "MedicalCondition",
"name": "Régions non traduites",
"code": {
"@type": "MedicalCode",
"code": "D020506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.137.910"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éléments riches en AU",
"alternateName": "AU Rich Elements",
"url": "https://questionsmedicales.fr/mesh/D063307",
"about": {
"@type": "MedicalCondition",
"name": "Éléments riches en AU",
"code": {
"@type": "MedicalCode",
"code": "D063307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.137.910.880.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Régions 3' non traduites",
"alternateName": "3' Untranslated Regions",
"code": {
"@type": "MedicalCode",
"code": "D020413",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fan Jiang",
"url": "https://questionsmedicales.fr/author/Fan%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Dong-Zhi Li",
"url": "https://questionsmedicales.fr/author/Dong-Zhi%20Li",
"affiliation": {
"@type": "Organization",
"name": "Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Kevin Struhl",
"url": "https://questionsmedicales.fr/author/Kevin%20Struhl",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA."
}
},
{
"@type": "Person",
"name": "Raffaella Liccardo",
"url": "https://questionsmedicales.fr/author/Raffaella%20Liccardo",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy."
}
},
{
"@type": "Person",
"name": "Marina De Rosa",
"url": "https://questionsmedicales.fr/author/Marina%20De%20Rosa",
"affiliation": {
"@type": "Organization",
"name": "Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Making clear and effective communication SOuND BETTeR for patients with communication barriers.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37844910",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1742-6723.14323"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perceived Communication Barriers by Caregivers of Psychiatric Patients.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37489673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i4.4249"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communication sheet eases barriers for Japanese patients and health professionals.",
"datePublished": "2022-07-30",
"url": "https://questionsmedicales.fr/article/35907847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-022-08371-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can ChatGPT rescue or assist with language barriers in healthcare communication?",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37591023",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pec.2023.107940"
}
},
{
"@type": "ScholarlyArticle",
"name": "Caring for older culturally and linguistically diverse patients with Cancer: Healthcare Providers' perceived barriers to communication.",
"datePublished": "2022-05-17",
"url": "https://questionsmedicales.fr/article/35589543",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgo.2022.04.009"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composants de gène",
"item": "https://questionsmedicales.fr/mesh/D040461"
},
{
"@type": "ListItem",
"position": 8,
"name": "Régions non traduites",
"item": "https://questionsmedicales.fr/mesh/D020506"
},
{
"@type": "ListItem",
"position": 9,
"name": "Régions 3' non traduites",
"item": "https://questionsmedicales.fr/mesh/D020413"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Régions 3' non traduites - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Régions 3' non traduites",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Régions 3' non traduites",
"description": "Comment identifier les 3' UTR dans un gène ?\nQuels tests sont utilisés pour étudier les 3' UTR ?\nLes 3' UTR sont-ils visibles sur des électrophorèses ?\nPeut-on détecter des mutations dans les 3' UTR ?\nQuel rôle jouent les 3' UTR dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Régions 3' non traduites",
"description": "Les 3' UTR sont-ils associés à des symptômes cliniques ?\nQuels symptômes peuvent résulter de mutations dans les 3' UTR ?\nLes 3' UTR affectent-ils la réponse aux traitements ?\nY a-t-il des symptômes spécifiques liés aux 3' UTR ?\nLes 3' UTR peuvent-ils être impliqués dans des syndromes ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Régions 3' non traduites",
"description": "Peut-on prévenir les maladies liées aux 3' UTR ?\nQuels conseils pour réduire les risques liés aux 3' UTR ?\nLes antécédents familiaux influencent-ils la prévention ?\nY a-t-il des programmes de prévention pour les 3' UTR ?\nComment le mode de vie affecte-t-il les 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Régions 3' non traduites",
"description": "Comment traiter les maladies liées aux 3' UTR ?\nLes thérapies ciblées affectent-elles les 3' UTR ?\nPeut-on modifier les 3' UTR pour traiter des maladies ?\nLes traitements peuvent-ils influencer les 3' UTR ?\nY a-t-il des médicaments ciblant les 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Régions 3' non traduites",
"description": "Quelles complications peuvent survenir avec les 3' UTR ?\nLes 3' UTR sont-ils liés à des cancers ?\nComment les 3' UTR affectent-ils la santé ?\nLes complications des 3' UTR sont-elles héréditaires ?\nY a-t-il des complications neurologiques liées aux 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Régions 3' non traduites",
"description": "Quels facteurs de risque sont associés aux 3' UTR ?\nL'environnement influence-t-il les 3' UTR ?\nLes habitudes de vie impactent-elles les 3' UTR ?\nLes mutations dans les 3' UTR sont-elles fréquentes ?\nY a-t-il des tests pour évaluer les risques liés aux 3' UTR ?",
"url": "https://questionsmedicales.fr/mesh/D020413?mesh_terms=Communication+Barriers#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les 3' UTR dans un gène ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les 3' UTR peuvent être identifiés par séquençage d'ARN et analyses bioinformatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les 3' UTR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le RT-PCR et les analyses de microarrays pour évaluer l'expression."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils visibles sur des électrophorèses ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les 3' UTR ne sont pas visibles directement sur les gels d'électrophorèse."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations dans les 3' UTR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations dans les 3' UTR peuvent être détectées par séquençage ciblé."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les 3' UTR dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la stabilité de l'ARN et l'expression des gènes, affectant le diagnostic."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils associés à des symptômes cliniques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, des anomalies dans les 3' UTR peuvent entraîner des symptômes par régulation génique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent résulter de mutations dans les 3' UTR ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations peuvent causer des maladies génétiques, entraînant divers symptômes."
}
},
{
"@type": "Question",
"name": "Les 3' UTR affectent-ils la réponse aux traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent influencer la réponse aux traitements en modifiant l'expression des gènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques liés aux 3' UTR ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement liés à des maladies spécifiques, pas aux 3' UTR eux-mêmes."
}
},
{
"@type": "Question",
"name": "Les 3' UTR peuvent-ils être impliqués dans des syndromes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des syndromes génétiques peuvent être associés à des mutations dans les 3' UTR."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux 3' UTR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage génétique peut aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "Quels conseils pour réduire les risques liés aux 3' UTR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain et se soumettre à des tests génétiques si nécessaire."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des programmes de prévention pour les 3' UTR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de sensibilisation et de dépistage génétique existent pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il les 3' UTR ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut influencer l'expression génique, y compris celle des 3' UTR."
}
},
{
"@type": "Question",
"name": "Comment traiter les maladies liées aux 3' UTR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la maladie sous-jacente, souvent par thérapies géniques ou médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées affectent-elles les 3' UTR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies ciblées peuvent moduler l'expression des gènes via les 3' UTR."
}
},
{
"@type": "Question",
"name": "Peut-on modifier les 3' UTR pour traiter des maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches de modification des 3' UTR sont en recherche pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils influencer les 3' UTR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent affecter la régulation des 3' UTR et l'expression génique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant les 3' UTR ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, peu de médicaments ciblent spécifiquement les 3' UTR, mais la recherche progresse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les 3' UTR ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies génétiques et des troubles de l'expression génique."
}
},
{
"@type": "Question",
"name": "Les 3' UTR sont-ils liés à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des altérations dans les 3' UTR peuvent être associées à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Comment les 3' UTR affectent-ils la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent l'expression des gènes, et des anomalies peuvent entraîner des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les complications des 3' UTR sont-elles héréditaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être héréditaires, selon les mutations présentes dans les 3' UTR."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées aux 3' UTR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations dans les 3' UTR peuvent être associées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux 3' UTR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des environnements spécifiques."
}
},
{
"@type": "Question",
"name": "L'environnement influence-t-il les 3' UTR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent affecter l'expression des gènes régulés par les 3' UTR."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie impactent-elles les 3' UTR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes de vie, comme le tabagisme, peuvent influencer l'expression des 3' UTR."
}
},
{
"@type": "Question",
"name": "Les mutations dans les 3' UTR sont-elles fréquentes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations dans les 3' UTR sont moins fréquentes que dans les régions codantes, mais significatives."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests pour évaluer les risques liés aux 3' UTR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent évaluer les risques associés aux mutations dans les 3' UTR."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, People's Republic of China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei 050082, P.R. China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
UT Southwestern Medical Center, Departments of Pharmacology and Biochemistry, Dallas, TX 75205, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Molecular and Cellular Biology, University of Washington, Seattle, WA 98195, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA; School of Medicine and Genome Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: ahsieh@fredhutch.org.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania 15282, United States.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Eye Center of Xiangya Hospital, Hunan Key Laboratory of Ophthalmology, Central South University, Changsha, China.
Publications dans "Régions 3' non traduites" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China.
Publications dans "Régions 3' non traduites" :
The consequences of ineffective communication between patients and clinicians in the ED range from frustration to significant adverse events. Unfortunately, scenarios where we are unable to understand...
Caregivers have significant role in effective treatment and recovery during hospitalization. Communication barriers in health care lead to poor treatment outcome of patients and caregiver's dissatisfa...
A cross-sectional study was conducted among 120 caregivers of psychiatric patients admitted in psychiatric ward of Patan Hospital who were selected by purposive sampling and interviewed using self-dev...
Low extent of communication barrier was perceived by 29.17%, great extent by 25.83%, moderate extent by 24.17% and no barriers were perceived by 20.83% caregivers. There was association between durati...
More than one fourth caregiver's perceived low extent of communication barrier, almost one fourth perceived great extent and less than one fourth perceived moderate extent. There was association betwe...
Language and cultural barriers can affect healthcare outcomes of minority populations. However, limited data are available on communication tools developed to address health disparities resulting from...
This study was conducted at a family health center in a United States urban setting, in the city of Pittsburgh, between November 2019 and August 2020. This study included Japanese adult patients who h...
Sixty Japanese patients met inclusion criteria and completed the survey. More than half of participants found the JECS useful, and those with self-reported limited English proficiency were most likely...
The JECS is a useful communication tool for addressing common barriers faced by Japanese patients seeking care at an American health center where Japanese-speaking physicians work but no clinic staff ...
This letter supplements some ideas put forward by Kim et al., who debated the importance of patient-centered communication as a central notion of patient-centered cancer care in pre- versus post-pande...
Due to various socio-cultural and language related factors, healthcare providers experience barriers when communicating with older culturally and linguistically diverse (CALD) patients with cancer, wh...
In order to lay out the healthcare providers' perceived barriers to communication, the present study identified and compared communication barriers among different healthcare providers when caring for...
An online survey was conducted among healthcare providers in the Netherlands who identified as being involved in the care of CALD patients with cancer (N = 191), specifically; GPs (N...
Overall, low Dutch language proficiency of older CALD patients with cancer, family interpreters providing inadequate translations, not knowing the extent of patients' informational needs, cultural dif...
Migrants and refugees may not access mental health services due to linguistic and cultural discordance between them and health and social care professionals (HSCPs). The aim of this review is to ident...
We undertook a rapid systematic review of the literature (01/01/2011 - 09/03/2022) on seeking and/or providing mental health services in linguistically discordant settings. Quality appraisal was perfo...
58/5,650 papers met the inclusion criteria. Both TCNs (and their carers) and HSCPs experience difficulties when seeking or providing mental health services and language barriers are present. TCNs and ...
Language barriers impede TCNs' access to mental health services. Improving language support options and cultural competency in mental health services is crucial to ensure that individuals from diverse...
Language plays a critical role in health communication, particularly in the management and understanding of non-communicable diseases (NCDs) among elderly populations. This study aimed to explore the ...
This qualitative phenomenological study was conducted with elderly participants aged 60 years and above, all of whom have chronic diseases. In-depth face-to-face interviews were conducted using an int...
Five major themes emerged regarding participants' understanding of NCDs and the perceived language barriers. These include Limited Knowledge and Awareness of NCDs, Misconceptions about NCDs, Mixed per...
The study revealed significant misconceptions about diabetes and hypertension, as well as traditional practices like bloodletting, which were perceived to relieve hypertension symptoms. It also identi...
Family doctors (FDs)/General practitioners (GPs) are the key contact points for young people and their parents regarding Human Papillomavirus (HPV) vaccination. However, their recommendations are infl...
Under the EU4Health project, PROTECT-EUROPE, WONCA Europe led a task to identify and analyse strategies for clinicians' interpersonal communication skills when discussing HPV and its vaccination with ...
Strengths, Weaknesses, Opportunities, Threats (SWOT) analysis using qualitative data focused on HPV vaccine acceptance and communication with the target population. FDs/GPs, members of WONCA Europe, w...
223 FDs/GPs from 36 countries participated. Strengths included face-to-face communication, extensively used to promote the HPV vaccine. Weaknesses involved financial constraints, limited knowledge abo...
It is crucial to train FDs/GPs to address knowledge gaps, enhance communication skills, and maintain a trusting relationship with patients when discussing HPV vaccination. Overcoming financial barrier...
Workers who experience language barriers are at increased risk of work-related injuries and illnesses and face difficulties reporting these health problems to their employer and workers' compensation....
This study merges data from two qualitative studies that investigated experiences with workers' compensation and return-to-work, respectively, for injured workers who experience language barriers. We ...
Almost all workers (34/39) had filed a claim, though most had initially delayed reporting their injuries or illnesses to their employer or to workers' compensation. Workers faced several obstacles to ...
Improving the linguistic and cultural competence of organizations and their representatives is insufficient to address under-reporting among workers who experience language barriers. Efforts to improv...
Understanding disparities in pediatric kidney transplants is important to provide equitable care. We compared transplant outcomes between English-speaking (ES) and interpreter-needing (IN) pediatric k...
Through retrospective review, primary kidney transplant recipients, 0-21 years transplanted between 2005 and 2019, were divided into ES and IN cohorts. Continuous and categorical variables were compar...
Our sample included 211 ES and 37 IN transplant recipients. Compared with the ES, the IN cohort was older at transplant (14.56 vs. 11.03 years; p < 0.01), had more time between kidney failure and tran...
Pediatric kidney transplant recipients requiring interpreter services for healthcare delivery demonstrate fewer post-transplant interactions with their healthcare team (fewer hospitalizations and more...